Zirconium-Porphyrin PCN-222: pH-responsive Controlled Anticancer Drug Oridonin

<div>Comparison of the antitumor activity of PCN-222@Ori and free Ori by incubating various concentrations of samples for 24 h, 48 h, and 72 h with HepG2 cells.</div>

Evidence-Based Complementary and Alternative Medicine

fig8

Figure 8

Figure 8: Zirconium-Porphyrin PCN-222: pH-responsive Controlled Anticancer Drug Oridonin 